LIQMEDS LIMITED |
Notes to the Accounts |
for the period from 7 November 2023 to 31 March 2024 |
|
|
1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Changes in the accounting reference dates |
|
During the year, the company changed its accounting reference date from 6 Novemeber to 31 March. As a result, the current financial statements cover a 5-month period from 7 November 2023 to 31 March 2024. The comparative figures cover a 10-month period from 1 January 2023 to 6 November 2023. |
|
|
Going concern |
|
The financial statements have been prepared on a going concern basis. The company has a net liability position as of the balance sheet date. However, the directors have received a letter of support from the parent company, which confirms that the parent will provide the necessary financial support to enable the company to meet its obligations as they fall due for at least the next 12 months from the date of approval of these financial statements. Based on this support, the directors believe that it is appropriate to prepare the financial statements on a going concern basis. |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Research and development |
|
Research and development expenditure is written off to the profit and loss account in the year in which it is incurred. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
2 |
Audit information |
|
|
The audit report is unqualified. |
|
|
Senior statutory auditor: |
Devender Arora ACA |
|
Firm: |
The Corporate Practice Limited |
|
Date of audit report: |
19 February 2025 |
|
|
3 |
Employees |
2024 |
|
2023 |
Number |
Number |
|
|
Average number of persons employed by the company |
0 |
|
0 |
|
|
|
|
|
|
|
|
|
|
4 |
Debtors |
2024 |
|
2023 |
£ |
£ |
|
|
Trade debtors |
1,016,042 |
|
745,138 |
|
Amounts owed by group undertakings |
|
1,652,229 |
|
- |
|
VAT refundable |
|
|
|
|
- |
|
503,377 |
|
Deferred tax asset |
|
|
|
|
656,161 |
|
- |
|
Other debtors |
- |
|
726,896 |
|
|
|
|
|
|
3,324,432 |
|
1,975,411 |
|
|
|
|
|
|
|
|
|
|
5 |
Creditors: amounts falling due within one year |
2024 |
|
2023 |
£ |
£ |
|
|
Trade creditors |
17,327 |
|
33,774 |
|
Amounts owed to group undertakings |
|
7,153,776 |
|
- |
|
|
|
(5,501,547) |
IC Balance |
|
Taxation and social security costs |
74,037 |
|
- |
|
Other creditors |
11,220 |
|
6,958,311 |
|
|
|
|
|
|
7,256,360 |
|
6,992,085 |
|
|
|
|
|
|
|
|
|
|
6 |
Events after the reporting date |
|
|
The directors confirm that there have been no significant events occurring after the balance sheet date that would require adjustment or disclosure in the financial statements. |
|
|
7 |
Related party transactions |
|
|
In accordance with Financial Reporting Standard 102 (FRS 102), the company has disclosed all related party transactions. Transactions with wholly-owned group members have been exempted from disclosure as permitted by paragraph 33.1A of FRS 102. Other related parties transactions are as below: |
|
|
UDAJ Limited |
|
Common director |
|
Included within other creditors is an amount due payable to UDAJ Limited of: |
|
- |
|
200,000 |
|
|
8 |
Controlling party |
|
|
Zydus Pharmaceuticals UK Limited is the controlling party. |
|
|
9 |
Other information |
|
|
LIQMEDS LIMITED is a private company limited by shares and incorporated in England. Its registered office is: |
|
Sandretto Building |
|
Cavalry Hill Industrial Park |
|
Weedon |
|
Northampton |
|
NN7 4PP |